FI104968B - Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI104968B
FI104968B FI942882A FI942882A FI104968B FI 104968 B FI104968 B FI 104968B FI 942882 A FI942882 A FI 942882A FI 942882 A FI942882 A FI 942882A FI 104968 B FI104968 B FI 104968B
Authority
FI
Finland
Prior art keywords
dihydro
imidazole
compound
formula
inden
Prior art date
Application number
FI942882A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942882A0 (fi
FI942882A (fi
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Maire Marjatta Eloranta
Antti Sakari Haapalinna
Jarmo Sakari Salonen
Hannu Tapani Sipilae
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Priority to FI942882A priority Critical patent/FI104968B/fi
Publication of FI942882A0 publication Critical patent/FI942882A0/fi
Publication of FI942882A publication Critical patent/FI942882A/fi
Application granted granted Critical
Publication of FI104968B publication Critical patent/FI104968B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
FI942882A 1991-12-20 1994-06-16 Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi FI104968B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI942882A FI104968B (fi) 1991-12-20 1994-06-16 Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9127050 1991-12-20
GB919127050A GB9127050D0 (en) 1991-12-20 1991-12-20 Substituted imidazole derivatives and their preparation and use
FI9200349 1992-12-18
PCT/FI1992/000349 WO1993013074A1 (en) 1991-12-20 1992-12-18 Substituted imidazole derivatives and their preparation and use
FI942882A FI104968B (fi) 1991-12-20 1994-06-16 Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi
FI942882 1994-06-16

Publications (3)

Publication Number Publication Date
FI942882A0 FI942882A0 (fi) 1994-06-16
FI942882A FI942882A (fi) 1994-06-16
FI104968B true FI104968B (fi) 2000-05-15

Family

ID=10706581

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942882A FI104968B (fi) 1991-12-20 1994-06-16 Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US5498623A (de)
EP (1) EP0618906B1 (de)
JP (1) JP3276371B2 (de)
AT (1) ATE165350T1 (de)
AU (1) AU664584B2 (de)
CA (1) CA2117305C (de)
DE (1) DE69225240T2 (de)
DK (1) DK0618906T3 (de)
ES (1) ES2115046T3 (de)
FI (1) FI104968B (de)
GB (1) GB9127050D0 (de)
HK (1) HK1008962A1 (de)
HU (1) HU220043B (de)
NO (1) NO304227B1 (de)
PL (1) PL172532B1 (de)
RU (1) RU2120440C1 (de)
WO (1) WO1993013074A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
EP2456749B1 (de) 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Indanderivate zur verwendung als zwischenprodukte
WO2011014613A2 (en) * 2009-07-31 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of fipamezole
EP2502917A1 (de) 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Im Festzustand kristalline Formen von 4-(2-Ethyl-5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol
WO2017079734A1 (en) * 2015-11-05 2017-05-11 University Of Louisville Research Foundation, Inc. Local and regional anesthesia and analgesia
LU103072B1 (en) * 2023-02-15 2024-08-19 Univ Ljubljani N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
WO2024160908A1 (en) * 2023-02-01 2024-08-08 Univerza V Ljubljani N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282535A (en) * 1970-03-02 1972-07-19 Pfizer (2-IMIDAZOLIN-2-YLAMINO)SUBSTITUTED BENZO[b]THIOPHENES
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
US3927018A (en) * 1974-12-23 1975-12-16 Sandoz Ag 3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
ES8503669A1 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB8409884D0 (en) * 1984-04-17 1984-05-31 Detexomat Machinery Ltd Transporting fabric pieces
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
SG77106A1 (en) * 1991-12-23 2000-12-19 Mobil Oil Corp Low oxygen transmissive film
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives

Also Published As

Publication number Publication date
CA2117305A1 (en) 1993-07-08
FI942882A0 (fi) 1994-06-16
NO942335L (no) 1994-06-20
HK1008962A1 (en) 1999-05-21
CA2117305C (en) 2003-11-25
DK0618906T3 (da) 1999-01-25
NO304227B1 (no) 1998-11-16
EP0618906A1 (de) 1994-10-12
DE69225240D1 (de) 1998-05-28
RU94031215A (ru) 1996-04-20
HU220043B (hu) 2001-10-28
AU664584B2 (en) 1995-11-23
DE69225240T2 (de) 1998-08-27
GB9127050D0 (en) 1992-02-19
WO1993013074A1 (en) 1993-07-08
JP3276371B2 (ja) 2002-04-22
FI942882A (fi) 1994-06-16
EP0618906B1 (de) 1998-04-22
PL172532B1 (en) 1997-10-31
ATE165350T1 (de) 1998-05-15
HU9401823D0 (en) 1994-09-28
AU3160593A (en) 1993-07-28
HUT67548A (en) 1995-04-28
JPH07506087A (ja) 1995-07-06
ES2115046T3 (es) 1998-06-16
NO942335D0 (no) 1994-06-17
RU2120440C1 (ru) 1998-10-20
US5498623A (en) 1996-03-12

Similar Documents

Publication Publication Date Title
FI104968B (fi) Menetelmä uusien terapeuttisesti aktiivisten substituoitujen imidatsolijohdannaisten valmistamiseksi
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
WO1999058495A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1149078B1 (de) Selektive 5-ht 6-rezeptor-liganden
EP0833818A1 (de) Verbindungen als rezeptor cb2 agonisten.
JP2004517852A (ja) インドール誘導体および５−ｈｔ２ｂおよび５−ｈｔ２ｃ受容体リガンドとしてのそれらの使用
FR2551439A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
HU197002B (en) Process for producing glutarimide derivatives
US6048862A (en) Benzylamidine derivatives with serotonin receptor binding activity
CA2246027A1 (en) Benzylamidine derivatives with serotonin receptor binding activity
US4782056A (en) 2-phenylhexahydro-1,2,4-triazine-3-,5-diones
US5925665A (en) Imidazoline compounds
EP2432766B1 (de) Antikrebsverbindung und pharmazeutische zusammensetzung, die diese enthält
Caroon et al. Structure-activity relationships for 2-substituted imidazoles as. alpha. 2-adrenoceptor antagonists
FR2769312A1 (fr) Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2744451A1 (fr) Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
FR2751647A1 (fr) Derives de benzimidazole, leurs preparations et leurs applications en therapeutique
CA2007401A1 (fr) Derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DK156396B (da) 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
BG104988A (bg) N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори
US3968230A (en) Compositions containing benzodiazepindiones and method of use
HU211271A9 (en) New optical isomers
GB2181731A (en) Fused bicyclic imides with psychotropic activity
HU211151A9 (hu) Szubsztituált imidazolszármazékok, előállításuk és alkalmazásuk
Toja et al. Anti-hypertensives: 1-alkyl-2-arylpiperazinoethyl-1H-naphth [1, 2-d] imidazoles

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: OY JUVANTIA PHARMA LTD.

GB Transfer or assigment of application

Owner name: OY JUVANTIA PHARMA LTD.

MA Patent expired